Balaji Arjuna Guggulu

Consult a healthcare practitioner if symptoms persist, worsen, or if you experience chest pain, vomiting, difficulty swallowing or breathing after product use. Do not use while pregnant or breastfeeding, or if you have diabetes, cardiovascular or thyroid disorders. Seek professional advice before use if taking blood thinners, protease inhibitors, beta-blockers, calcium channel blockers, coagulation disorders or antiplatelet medication. Discontinue use if gastrointestinal discomfort, headache, and/or skin rash occur.

Contra-Indications:

Do not use if you have difficulty swallowing. Do not use this product if you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product.

Known Adverse Reactions:

May cause temporary gas and/or bloating. Stop use if hypersensitivity/allergy occurs.

The following information is provided for educational purposes only. It does not represent health claims for this product and should not be taken as medical advice. Always consult a qualified health care practitioner before starting any new supplement.

Ingredients

• Terminalia arjuna (Arjuna): Clinical and pharmacological research highlights antioxidant, cardioprotective, and lipid-lowering properties. Human studies report improvements in blood pressure, cholesterol, and inflammatory markers in coronary artery disease patients (Das 2020; Ramesh 2023; Rajaram 2024).
  
• Commiphora mukul (Guggul): Contains guggulsterones, which act on bile metabolism and lipid regulation. Research supports its antihyperlipidemic and anti-inflammatory activity, with Ayurvedic practice distinguishing between “new” and “old” guggul preparations (Barbagallo 2015; Yang 2024; Vyas 2015).
  
• Allium sativum (Garlic): Rich in bioactive organosulfur compounds such as allicin, garlic demonstrates antioxidant, anti-inflammatory, antihypertensive, and lipid-lowering effects. Systematic reviews confirm reductions in cholesterol, triglycerides, and blood pressure in both animal and human studies (Shang 2019; Imaizumi 2023).
  
• Plantago ovata (Isabgol/Psyllium): Fiber-rich husk shown to reduce serum cholesterol by binding bile acids, lowering intestinal cholesterol absorption, and reducing hepatic cholesterol synthesis. Psyllium is recognized as a supportive agent in hyperlipidemia therapy (Turgut 2021).
  

References

Barbagallo CM, et al. (2015). Role of nutraceuticals in hypolipidemic therapy. Front Cardiovasc Med, 2:22. https://doi.org/10.3389/fcvm.2015.00022

Das G, et al. (2020). Plants of the genus Terminalia: biological potentials and clinical studies. Front Pharmacol, 11:561248. https://doi.org/10.3389/fphar.2020.561248

Imaizumi VM, et al. (2023). Garlic: systematic review of cardiovascular effects. Crit Rev Food Sci Nutr, 63(24):6797–6819. https://doi.org/10.1080/10408398.2022.2043821

Ramesh P, Palaniappan A. (2023). Terminalia arjuna, a cardioprotective herbal medicine. Pharmaceuticals, 16(1):126. https://doi.org/10.3390/ph16010126

Rajaram V, et al. (2024). Terminalia arjuna: overview of its cardiac properties. Bioinformation, 20(12):2080–2085. https://doi.org/10.6026/9732063002002080

Shang A, et al. (2019). Bioactive compounds and functions of garlic. Foods, 8(7):246. https://doi.org/10.3390/foods8070246

Turgut R, et al. (2021). Cholesterol-lowering formulations using psyllium. Front Pharmacol, 12:775789. https://doi.org/10.3389/fphar.2021.775789

Yang Y, et al. (2024). The genus Commiphora: traditional uses, phytochemistry, and pharmacology. Pharmaceuticals, 17(11):1524. https://doi.org/10.3390/ph17111524

Vyas KY, et al. (2015). Comparative anti-hyperlipidemic activity of Navīna and Purāṇa Guggulu. Anc Sci Life, 35(2):101–109. https://doi.org/10.4103/0257-7941.171672